A national leader in medicine with impeccable credentials, Dr. Makary is imminently qualified to lead the FDA at this important time in the health of our nation,” the email, obtained by STAT, reads. It’s a shaky start for Makary,

WASHINGTON — The Food and Drug Administration’s chief tobacco regulator has been removed from his post as part of sweeping cuts to the federal health workforce on Tuesday, the latest in a series of actions that have cleared out many of the nation's top experts overseeing food, drugs, vaccines and tobacco products.

Both agencies are part of the Department of Health and Human Services, which like much of the federal government, has seen mass layoffs as part of the Trump administration's ongoing efforts to implement budget cuts.

Fox News contributor Dr. Marty Makary was officially confirmed to lead the FDA in Trump's second administration after a vote on Tuesday night.

Biotech stocks skidded again Tuesday as "chaos" reigned at the FDA with reports of mass firings, including the departure of a key official.

When Marty Makary officially became Food and Drug Administration commissioner Tuesday night, he inherited the explosive matter of mifepristone access — an issue that hung over and complicated his confirmation process.

The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug Administration. During his confirmation hearing, Makary said his goals for the agency were "more cures and meaningful treatments for Americans.

By Leah Douglas, Marisa Taylor and Julie SteenhuysenWASHINGTON (Reuters) -The Trump administration began mass layoffs of 10,000 staffers at U.S. health agencies on Tuesday, according to multiple sources familiar with the situation,

Marty Makary, at FDA, and Jay Bhattacharya, at NIH, are assuming leadership of agencies pummeled by workforce cuts and sagging morale.